However, tumor cells tend to be self-origin and are inherently not very immunogenic, hence failure to be recognized by APCs is generally the major obstacle for cancer immunotherapy including PD-1 blockade therapy [27, 31]. The gene discussed is PDCD1; the disease is neoplasm.